Graham Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Graham Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$108K	Buy	+30,821	New	+$126K	﹤0.01%	1033
2025 Q3	–	Sell	-523,378	Closed	-$375K	–	1450
2025 Q2	$375K	Buy	523,378 +319,840	+157%	+$251K	0.01%	921
2025 Q1	$299K	Buy	203,538 +140,506	+223%	+$335K	0.01%	998
2024 Q4	$279K	Sell	63,032 -44,938	-42%	-$182K	﹤0.01%	961
2024 Q3	$445K	Buy	+107,970	New	+$580K	0.01%	667
2024 Q2	–	Sell	-13,537	Closed	-$118K	–	1189
2024 Q1	$118K	Buy	+13,537	New	+$164K	﹤0.01%	959
2022 Q4	–	Sell	-18,177	Closed	-$188K	–	1172
2022 Q3	$188K	Sell	18,177 -74,900	-80%	-$849K	0.01%	994
2022 Q2	$1.07M	Buy	+93,077	New	+$1.1M	0.04%	415
2022 Q1	–	Sell	-24,724	Closed	-$288K	–	951
2021 Q4	$288K	Buy	+24,724	New	+$303K	0.01%	340

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Graham Capital Management's IRWD Position: Q1 2026 in Review

Graham Capital Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 30,821 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #1033 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in IRWD as recently as Q2 2025.

Graham Capital Management first reported a position in IRWD in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.07M in Q2 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Graham Capital Management held 30,821 shares of Ironwood Pharmaceuticals worth $108K as of Q1 2026.
Ironwood Pharmaceuticals was a new Graham Capital Management position in Q1 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Graham Capital Management's portfolio in Q1 2026, its #1033 holding.
Graham Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
Graham Capital Management's Ironwood Pharmaceuticals position peaked at $1.07M in Q2 2022.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.